Literature DB >> 7969274

Kinetoplastidae display naturally occurring ancillary DNA-containing structures.

Y Miyahira1, J A Dvorak.   

Abstract

Kinetoplast-derived, DNA-containing structures were found in several members of the order Kinetoplastida. The structures, for which we propose the name ancillary DNA-containing structures (aDNA), were discovered during the course of low-light-level video fluorescence microscopy studies using several nucleic acid-specific fluorescent reagents. DNase treatment and supravital stain with Höechst 33342 confirmed that aDNA is not an artifact of specimen preparation. Fluorescent in situ hybridization using either a 122-bp kinetoplast DNA-specific probe derived from a conserved region of minicircle DNA or a 188-bp nuclear DNA-specific probe derived from highly repetitive nuclear DNA demonstrated that aDNA is derived from the kinetoplast and not the nucleus. However, the structures do not contain minicircle DNA replication intermediates. Immunofluorescence assays using an anti-mitochondrial protein antibody, anti-mtp70, demonstrated that the structures contain mitochondrial protein and confirmed their kinetoplast origin. The frequency of occurrence of aDNA varies markedly between members of the Kinetoplastida. In the case of Trypanosoma cruzi stocks, the percentage of cells with aDNA was positively correlated to the population doubling time of the stock. However, there is no statistically significant relationship between the developmental or replicative stage of the parasite and the frequency of aDNA. An inhibitor of DNA topoisomerase I had no effect upon the frequency of aDNA. An inhibitor of DNA topoisomerase II gave equivocal results depending upon the parasite stock used. We speculate that aDNA may be the morphological consequence of a yet-to-be-determined biological process intrinsic to but variable within the Kinetoplastida.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969274     DOI: 10.1016/0166-6851(94)90084-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.

Authors:  Eiji Takayama; Takeshi Ono; Elena Carnero; Saori Umemoto; Yoko Yamaguchi; Atsuhiro Kanayama; Takemi Oguma; Yasuhiro Takashima; Takushi Tadakuma; Adolfo García-Sastre; Yasushi Miyahira
Journal:  Int J Parasitol       Date:  2010-07-08       Impact factor: 3.981

2.  Depletion of mitochondrial acyl carrier protein in bloodstream-form Trypanosoma brucei causes a kinetoplast segregation defect.

Authors:  April M Clayton; Jennifer L Guler; Megan L Povelones; Eva Gluenz; Keith Gull; Terry K Smith; Robert E Jensen; Paul T Englund
Journal:  Eukaryot Cell       Date:  2011-01-14

3.  A DNA polymerization-independent role for mitochondrial DNA polymerase I-like protein C in African trypanosomes.

Authors:  Jonathan C Miller; Stephanie B Delzell; Jeniffer Concepción-Acevedo; Michael J Boucher; Michele M Klingbeil
Journal:  J Cell Sci       Date:  2020-05-07       Impact factor: 5.285

4.  Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.

Authors:  Yasushi Miyahira; Masaharu Katae; Kazuyoshi Takeda; Hideo Yagita; Ko Okumura; Seiki Kobayashi; Tsutomu Takeuchi; Tsuneo Kamiyama; Yoshinosuke Fukuchi; Takashi Aoki
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

5.  Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.

Authors:  Yasushi Miyahira; Yasuhiro Takashima; Seiki Kobayashi; Yasunobu Matsumoto; Tsutomu Takeuchi; Mutsuko Ohyanagi-Hara; Ayako Yoshida; Akihiko Ohwada; Hisaya Akiba; Hideo Yagita; Ko Okumura; Hideoki Ogawa
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection.

Authors:  Yasushi Miyahira; Masaharu Katae; Seiki Kobayashi; Tsutomu Takeuchi; Yoshinosuke Fukuchi; Ryo Abe; Ko Okumura; Hideo Yagita; Takashi Aoki
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.

Authors:  Masaharu Katae; Yasushi Miyahira; Kazuyoshi Takeda; Hironori Matsuda; Hideo Yagita; Ko Okumura; Tsutomu Takeuchi; Tsuneo Kamiyama; Akihiko Ohwada; Yoshinosuke Fukuchi; Takashi Aoki
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  The Trypanosoma cruzi nucleic acid binding protein Tc38 presents changes in the intramitochondrial distribution during the cell cycle.

Authors:  María A Duhagon; Lucía Pastro; José R Sotelo-Silveira; Leticia Pérez-Díaz; Dante Maugeri; Sheila C Nardelli; Sergio Schenkman; Noreen Williams; Bruno Dallagiovanna; Beatriz Garat
Journal:  BMC Microbiol       Date:  2009-02-11       Impact factor: 3.605

9.  Mitochondrial heat shock protein machinery hsp70/hsp40 is indispensable for proper mitochondrial DNA maintenance and replication.

Authors:  Jiří Týč; Michele M Klingbeil; Julius Lukeš
Journal:  mBio       Date:  2015-02-10       Impact factor: 7.867

10.  Trypanosoma brucei PUF9 regulates mRNAs for proteins involved in replicative processes over the cell cycle.

Authors:  Stuart K Archer; Van-Duc Luu; Rafael A de Queiroz; Stefanie Brems; Christine Clayton
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.